Amarin Corp Plc (AMRN)

[Hondo1021]

There is something wrong structurally with the script numbers. Refills should be a much higher multiple of new scripts. Vascepa is not like taking aspirin to make a headache go away and then your done. It should be taken for a much longer time (as long as someone wants protection against hi trigs and CVD events). We know anecdotally that Vascepa is well tolerated. So if I have a chronic CVD condition and begin taking Vascepa, I should have one new script and many refills 11X/year or 4X/year and ideally continue taking this for many years.

The Symphony-reported numbers show refills only 20% higher than new scripts. I would expect a significantly higher multiple. Something like 300% to 1000% by now.

So something doesn't add up. Are the pills too onerous to take? Are they too big to swallow? Is the data WAY off? I mean, if I had a heart attack and my doctor said I likely wouldn't get another one if i took these pills, I'd take them for the rest of my life. So, what gives?